Association of Cannabis Use With Guideline-Recommended Cancer Screenings: Results From a National Health Behaviors Survey
Heavy cannabis use was associated with lower adherence to recommended breast and prostate cancer screenings, while moderate cannabis use was associated with reduced prostate cancer screening adherence only. This effect was not seen in cervical and colorectal cancer screening. Close monitoring of adherence to breast cancer screening in women and prostate cancer screening in men with frequent cannabis use might be beneficial.
Authors
- Zhiyu Qian
- Giovanni Lughezzani (ORCID: https://orcid.org/0000-0003-3939-4521)
- Nicolò Maria Buffi (ORCID: https://orcid.org/0000-0003-2436-9091)
- Daniel Stelzl
- Hanna Zurl
- Adam S. Kibel (ORCID: https://orcid.org/0000-0002-9446-7781)
- Quoc‐Dien Trinh (ORCID: https://orcid.org/0000-0003-3857-9276)
- Alexander P. Cole (ORCID: https://orcid.org/0000-0002-0049-8529)
- Filippo Dagnino
- Stephan M. Korn
- Klara Pohl (ORCID: https://orcid.org/0009-0001-6740-4005)
Institutions
- Brigham and Women's Hospital (US)
- Humanitas University (IT)
- Harvard University (US)
- Universität Hamburg (DE)
- University of Pittsburgh (US)
- Medical University of Graz (AT)
- University Medical Center Hamburg-Eppendorf (DE)
- IRCCS Humanitas Research Hospital (IT)
- Medical University of Vienna (AT)
Publication Details
- Journal
- JCO Oncology Practice
- Published
- 2025-06-27
- DOI
- https://doi.org/10.1200/op-24-01093
- Citations
- 1
- Primary Topic
- Cannabis and Cannabinoid Research
- Type
- article
- Field-Weighted Citation Impact
- 1.39